NASDAQ:BBI
Delisted
Brickell Biotech Inc. Stock News
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
One of Wales' leading life sciences firms BBI expands with German acquisition
10:53am, Thursday, 04'th Jun 2020
The Crumlin headquartered firm has acquired DIARECT
BRICKELL BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K) | MarketScreener
09:01pm, Tuesday, 02'nd Jun 2020What We Know About Selling Sunset Star Maya Vander’s Husband
05:40pm, Monday, 01'st Jun 2020
After some internet sleuthing, Mary's husband's name has been revealed.
Brickell Biotech (NASDAQ:BBI) Is Arguably In A Tricky Situation
12:04pm, Sunday, 31'st May 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
BRICKELL BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) | MarketScreener
08:09pm, Wednesday, 13'th May 2020Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update | MarketScreener
08:02pm, Wednesday, 13'th May 2020Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Wednesday, 13'th May 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020 | MarketScreener
08:06pm, Monday, 04'th May 2020Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020
08:05pm, Monday, 04'th May 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
